Roivant Sciences
ROIV
78 hedge funds and large institutions have $1.19B invested in Roivant Sciences in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 7 closing their positions.
155% more call options, than puts
Call options by funds: $566K | Put options by funds: $222K
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
59% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 17
10% more funds holding
Funds holding: 71 → 78 (+7)
1.23% more ownership
Funds ownership: 51.44% → 52.67% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
19% less capital invested
Capital invested by funds: $1.47B → $1.19B (-$274M)
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$10.5M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$9.68M |
| 3 |
TSC
Two Seas Capital
Rye,
New York
|
+$9.49M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.49M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.57M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.57M |
| 2 |
PT
Palantir Technologies
Denver,
Colorado
|
-$2.9M |
| 3 |
SCM
Suvretta Capital Management
New York
|
-$2.77M |
| 4 |
CC
Centiva Capital
New York
|
-$1.35M |
| 5 |
State Street
Boston,
Massachusetts
|
-$742K |
ROIV Hedge Fund Activity: Q3 2022 in Review
78 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q3 2022, worth a combined $1.19B — down 19% from $1.47B a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new ROIV positions and 7 closed out — a net gain of 8 holders — while 27 added to existing stakes and 17 trimmed.
The largest buyer was Adage Capital Partners, adding an estimated $10.5M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $3.57M sold.
- 78 institutional investors held Roivant Sciences (ROIV) as of Q3 2022, up from 71 in Q2 2022.
- Funds reported $1.19B of Roivant Sciences stock for Q3 2022, down 19% quarter-over-quarter.
- 15 funds opened new Roivant Sciences positions in Q3 2022 and 7 closed out, a net change of +8 holders.
- The largest Roivant Sciences buyer in Q3 2022 was Adage Capital Partners, an estimated $10.5M added.
- The largest Roivant Sciences seller in Q3 2022 was Point72 Asset Management, an estimated $3.57M sold.
Based on aggregated 13F filings for Q3 2022.